Cytogenetics available

Slides:



Advertisements
Similar presentations
Molecular Haemato-Oncology at Bristol Genetics Laboratory
Advertisements

Application of FISH in hematologic malignancies
Identification and RQ-PCR monitoring of CML patients with rare variant BCR-ABL transcripts Chris Bowles West Midlands Regional Genetics Laboratory.
GT training- A GOSH experience Sumera Ghani Great Ormond St Hospital London Paediatric Malignancy Unit.
Susanna Akiki WMRGL 2009 Acute Promyelocytic Leukemia with t(15;17) (q22;q21) developing inv(16)(p13q22) secondary AML.
UNITID INTRODUCES THE SCREENING OF MYELOGENOUS LEUKAEMIA BY USE OF XPERT BCR –ABL MONITOR UNITID recently started screening for the Philadelphia chromosome.
Acute Myeloid Leukaemia— phenotype and genotype
Fluorescence in situ Hybridization
Converting BCR-ABL1 to the International Scale: Standardizing the Measurement of Relative Gene Expression Charles E. Hill Emory University School of Medicine.
Chronic myeloid leukaemia. THE STORY OF CHRONIC MYELOID LEUKAEMIA ‘It is moreover, the same conclusion which Bennett came to in the much-discussed matter.
Marty O’Neill II Carmen Banea
Products of haematopoiesis. Leukaemia, the current hypothesis Defect in maturation of white blood cells-may involve a block in differentiation and/or.
Heterogeneity of Abnormal RUNX1 Leading to Clinicopathological Variations in Childhood B-Lymphoblastic Leukemia Xiayuan Liang, MD Department of Pathology.
Molecular Medicine Dr Catherine Flynn Consultant Haematologist St James’s Hospital October 22 nd 2009.
Normal haemopoiesis. ABNORMALITIES IN THE HEMOPOIETIC SYSTEM CAN LEAD TO HEMOGLOBINOPATHIES HEMOPHILIA DEFECTS IN HEMOSTASIS/THROMBOSIS HEMATOLOGICAL.
A Novel Approach for Unique MRD Markers Identification in Acute Leukemia Patients Tereza Jančušková synlab genetics s.r.o. Evropska 176/16, Prague, Czech.
AUTHOR: POP MARIA CRISTINA COAUTHOR: SIMON MELANIA RENATA COORDINATORS: IOAN JUNG, SIMONA GURZU.
Case Study MICR Hematology Spring, 2011 Case # 5 Hee Jin Kim, Hooman Nikizad and Arthur Omuro.
M. Sales1, N. Foster1, S. Tauro2, J. Cunningham1, N. Pratt1
Molecular Monitoring in CML the process and questions we can answer Letizia Foroni.
Case 255 Elizabeth Courville, MD Robert Hasserjian, MD Massachusetts General Hospital Society for Hematopathology/European Association for Haematopathology.
(NAAC Accredited ‘A’ grade)
INTRODUCTION & OBJECTIVES Introduction: The carcinogenesis of hepatocellular carcinoma (HCC) is a multifactorial, multistep and complex process. Its prognosis.
P Ferguson, R Hills, A Grech, L Kjeldsen, M Dennis, P Vyas, R Clark, N Russell, C Craddock, On behalf of the NCRI AML Working Group. An operational definition.
CASE 411 Jose Gonzalez-Berjon, MD & Tariq Muzzafar, MD UT M.D. Anderson Cancer Center.
The Challenge of Monitoring CML When Resources Are Limited Jorge Cortes, MD Chief, CML & AML Section Department of Leukemia MD Anderson Cancer Center.
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
Case 11: Near-haploid B lymphoblastic leukemia with an apparent hyperdiploid karyotype Rebecca King MD Sarah Choi MD PhD, Peter Papenhausen PhD, and Gerald.
Adam J. Wood, D.O. Rhett P. Ketterling, M.D. April E. Chiu, M.D.
Figure 6: BTK splice variants in B cell precursor leukemia
Session 7, case 171 Extramedullary Manifestations of Myeloid Neoplasms
Shah N et al. Proc ASH 2010;Abstract 206.
Davood zare-Abdollahi, Ph.D
Soverini S et al. Proc ASH 2015;Abstract 346.
Acute Myeloid Leukemia
Advances in the Management of Pediatric Acute Leukemia
CLINICAL PROGRESSION INTRODUCTION METHOD CONCLUSION REFERENCES
Molecular consequences of chromosomal rearrangements that modify the AML1/CBFβ transcription factor complex, the most frequent target of reciprocal translocations.
Early Molecular and Cytogenetic Response Predict for Better Outcomes in Untreated Patients with CML-CP — Comparison of 4 TKI Modalities (Standard- and.
Note: A multivariate analysis suggests that a model that adds clinical and demographic information may perform better than the nomogram alone. (See O'Neill.
P. Code (A ) Material and Methods Results Conclusion
FLT3 Internal Tandem Duplication(ITD) mutation in Acute Myeloid Leukemia and its clincopathological correlation – Study from a tertiary care centre in.
P.-Y. Lévy  Clinical Microbiology and Infection 
Claudio Lottaz and Rainer Spang
HS 4160 Critical Scientific Analysis
Leukemia Human Disease Asma Siddique BIOT 412.
Monitoring Milestones in Patients With Chronic Myeloid Leukemia
The role of Minimal Residual Disease in
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
Acute Myeloid Leukemia
The PML Gene Breakpoint in Acute Promyelocytic Leukemia and
Case:2 leukemia دينا نعمان جرادة جيهان ايمن مقاط.
Best Practices in Chronic Myeloid Leukemia by Multidisciplinary Teams
Ayalew Tefferi, M.D.  Mayo Clinic Proceedings 
by David Grimwade, and Sylvie D. Freeman
Lymphoid Preponderance and the Absence of Basophilia
Daynna J. Wolff, Adam Bagg, Linda D. Cooley, Gordon W. Dewald, Betsy A
Jianbo Song, Danielle Mercer, Xiaofeng Hu, Henry Liu, Marilyn M. Li 
BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1–positive B-cell acute lymphoblastic leukemia by Karen A. Dun, Rob Vanhaeften, Tracey J.
Introduction Results Materials and Methods Conclusions References 1
2017 ELN Risk Stratification by Genetics
Fluorescence In Situ Hybridization Identifies Cryptic t(16;16)(p13;q22) Masked By del(16)(q22) in a Case of AML-M4 Eo  Shakil H. Merchant, Skip Haines,
Cytogenetics Part 2 Dr. Mohammed Hussein
Sanger sequencing results
Introduction & haematological malignancies
Kantarjian HM et al. Blood 2008;112:Abstract 635.
Claudio Lottaz and Rainer Spang
How I treat T-cell acute lymphoblastic leukemia in adults
Presentation transcript:

Cytogenetics available COMPARATIVE ANALYSIS OF MOLECULAR GENETIC AND CONVENTIONAL CYTOGENETIC DETECTION OF DIAGNOSTICALLY IMPORTANT TRANSLOCATIONS Biswajoy Pal, Dr. Deepak Mishra, Dr. Mayur Parihar,  Poonam Santra, Sourav Sarma Chowdhury, Dr. Saurabh Bhave, Dr. Anupam Chakrapani, Dr Arpita Bhattacharya, Dr Shekhar krishnan, Dr. Reena Nair, Dr Vaskar Saha, Dr. Mammen Chandy, Dr. Neeraj Arora. Department of Molecular Genetics & Cytogenetics, Tata Medical Center, Kolkata. 2014 INTRODUCTION RESULTS Fig-3: concordance and discordance results of karyotyping, FISH and RT-PCR The contemporary diagnosis of leukaemia relies on a multifaceted approach. Techniques like cytogenetics, RT-PCR and FISH are the commonly used methods in the diagnostic laboratory. Though many translocations can be detected by cytogenetics alone, RT-PCR and FISH are increasingly used for detection of diagnostically significant translocations in a clinical laboratory. The aim of the study was to test the usefulness of these three techniques for detection of common recurrent chromosomal translocations in leukemia so that they can be used in a cost effective manner. 486 specimens from 239 unique patients were tested by RT-PCR for seven common translocations: t(8;21), t(15;17), inv(16), t(9;22), t(12;21), t(4;11), and t(1;19), with a detection rate of 18.9% (92/486) in 2 years. Of 92 positive cases, 30 having previous treatment history were excluded. Of remaining 62, FISH analysis was performed on 44 (71%) and karyotyping in 30 (48.4%) cases only. Discordance rate of RT-PCR/FISH and RT-PCR/karyotyping was 4.5% (2/44) and 6.6% (2/30). Both these cases were diagnosed as APML. Total RTPCR positive n=62 FISH available n=44 Concordant 42 (95.4%) Discordant 2 (4.5%) Cytogenetics available n=30 28 (93.3%) 2 (6.6%) CONCLUSION This analysis shows 8.3%(2/24) PML-RARA [(t15;17)] discordance between both karyotyping/RT-PCR and FISH/RT-PCR due to cryptic translocation in ALL cases which was not detected by karyotyping and/or FISH. Both Conventional Cytogenetics and Molecular Genetics based assays are powerful diagnostic tools for detection of chromosomal aberrations in leukemias. Although there is sporadic discordance between these two techniques and each method has its own limitations, the judicious use of these techniques will deliver the best cost effective treatment in leukaemias. ENMZ(MALT) Fig-1 :LIST OF RT-PCR POSITIVE CASES AT DIAGNOSIS MATERIALS AND METHODS Total at diagnosis RT-PCR positive n=62 CML positive n = 17 ALL positive n = 21 BCR-ABL positive n= 12 E2A-PBX positive n = 4 MLL-AF4 positive n = 1 TEL-AML1 positive n = 4 APML positive n = 24 This is a retrospective study carried out in the Department of Molecular Genetics and Cytogenetics, Tata Medical Center, Kolkata. All newly diagnosed cases of acute leukemia from August 2012 to August 2014 referred for RT-PCR analysis were included. Patients were diagnosed and sub classified according to the WHO 2008 classification. All RT-PCR positive cases were compared to the karyotyping and/or FISH wherever available. Cytogenetic and FISH analyses were carried out using standard protocols. All patients with leukemia at diagnosis who were positive for any of the fusion transcripts by RT-PCR, were included in this study. Table-1 : concordance and discordance of karyotyping, FISH and RT-PCR in various tested molecular aberrations Particulars Diagnosis   CML APML Ph+ALL t{12;21} t{1;19} Total cases 17 24 10 4 Concordance RT-PCR/ Karyotyping (%) 100 (17/17) 91.7 (22/24) (6/6) (4/4) (2/2) Discordance RT-PCR/ Karyotyping (%) (0/17) 8.3 (2/24) (0/6) (0/4) (0/2) Concordance RT-PCR/FISH (%) NA Discordance RT-PCR/FISH (%) REFERENCES • WHO classification of tumuors,2008. • A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias. MC Cox et al, Am J Clin Pathol. 1998 Jan;109(1):24-31.